Infección por el VIH (II)

  1. Martín Aspas, Andrés
  2. Collado Pérez, María Concepción
  3. Montes de Oca Arjona, M.
  4. Orozco Cózar, M. J.
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2014

Issue Title: Enfermedades infecciosas (I): infecciones víricas, infección por VIH

Series: 11

Issue: 49

Pages: 2902-2911

Type: Article

DOI: 10.1016/S0304-5412(14)70713-9 DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

Given the efficacy of current antiretroviral therapy, infections incidence in compliant patients has decreased, arising frequency of neoplastic disease. Tumors are often the first complication of HVI infection, especially AIDS-defining malignancies, although other tumors occur more frequently in these patients. We describe the presentation, diagnosis, treatment and prevention of the most prevalent. Infections are related to the level of CD4 lymphocytes and prophylaxis for opportunistic infections; treatment has not changed much, but new techniques for diagnosis are available, which interpretation is important to know. Rheumatologic diseases are less prevalent, but we review the most frequent and its presentation.

€ View funding

Funding information

56 2013 143 150 28. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. [Consultado 12 de agosto 2013]. Disponible en: aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf . 29. Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) A. Mocroft P. Reiss O. Kirk C. Mussini E. Girardi P. Morlat

Funders

Bibliographic References

  • M.S. Shiels, S.R. Cole, G.D. Kirk, C. Poole A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals J Acquir Immune Defic Syndr, 52 (2009), pp. 611-622
  • H.W. Jaffe, B.L. De Stavola, L.M. Carpenter, K. Porter, D.R. Cox, CASCADE collaboration Immune reconstitution and risk of Kaposi sarcoma and non- Hodgkin lymphoma in HIV-infected adults AIDS, 25 (2011), pp. 1395-1403
  • M. Bower, S. Collins, C. Cottrill, K. Cwynarski, S. Montoto, M. Nelson AIDS Malignancy Subcommittee British HIV Association guidelines for HIV-associated malignancies 2008 HIV Med, 9 (2008), pp. 336-388
  • E.B. El Amari, L. Toutous Trellu, A. Gayet Ageron, M. Baumann, G. Cathomas, I. Steffen Swiss HIV Cohort Study Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era AIDS, 22 (2008), pp. 1019-1028
  • J. Stebbing, A. Sanitt, M. Nelson, T. Powles, B. Gazzard, M. Bower A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy Lancet, 367 (2006), pp. 1495-1502
  • S.E. Krown, D.P. Dittmer, E. Cesarman Pilot study of oral valganciclovir therapy in patients with classic Kaposi sarcoma J Infect Dis, 203 (2011), pp. 1082-1086
  • C. Chao, L. Xu, D.I. Abrams, W.J. Towner, M.A. Horberg, W.A. Leyden HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons AIDS, 25 (2011), pp. 1771-1777
  • P. Miralles, J. Berenguer, J.M. Ribera, F. Calvo, J. Díaz, J.L. Díez-Martín Recomendaciones de GESIDA/PETHEMA sobre el diagnóstico y el tratamiento de los linfomas en pacientes infectados por el virus de la inmunodeficiencia humana Med Clin (Barc), 130 (2008), pp. 300-311
  • O. Landgren, J.J. Goedert, C.S. Rabkin, W.H. Wilson, K. Dunleavy, R.A. Kyle Circulating serum free light chains as predictive markers of AIDSrelated lymphoma J Clin Oncol, 28 (2010), pp. 773-779
  • A. Antinori, G. De Rossi, A. Ammassari, A. Cingolari, R. Murri, D. Di Giuda Value of combined approach with thallium-201 single photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma J Clin Oncol, 17 (1999), pp. 554-560
  • S. Pipkin, S. Scheer, I. Okeigwe, S. Schwarcz, D.H. Harris, N.A. Hessol The effect of HAART and calendar period on Kaposi's sarcoma and non- Hodgkin lymphoma: results of a match between an AIDS and cancer registry AIDS, 25 (2011), pp. 463-471
  • L.D. Kaplan, J.Y. Lee, R.F. Ambinder, J.A. Sparano, E. Cesarman, ChadburnA Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non Hodgkin lymphoma: AIDS-Malignancies Consortium Trial010 Blood, 106 (2005), pp. 1538-1543
  • S.K. Barta, J.Y. Lee, L.D. Kaplan, A. Noy, J.A. Sparano Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma Cancer, 118 (2012), pp. 3977-3983
  • A.L. Akinwuntan, O.A. Adesina, C.A. Okolo, O.A. Oluwasola, A. Oladokun, A.A. Ifeneje Correlation of cervical cytology and visual inspection with acetic acid in HIV-positive women J Obstet Gynaecol, 28 (2008), pp. 638-641
  • M. Bower, D. Mazhar, J. Stebbing Should cervical cancer be an acquired immunodeficiency syndrome defining cancer? J Clin Oncol, 24 (2006), pp. 2417-2419
  • P. Patel, D.L. Hanson, P.S. Sullivan, R.M. Novak, A.C. Moorman, T.C. Tong Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003 Ann Intern Med, 148 (2008), pp. 728-736
  • A. Kesselring, L. Gras, C. Smit, G. van Twillert, A. Verbon, F. de Wolf Immunodeficiency as a risk factor for non AIDS defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy Clin Infect Dis, 52 (2011), pp. 1458-1465
  • K.A. Lichtenstein Antiretroviral treatment interruptions and risk of nonopportunistic diseases Curr HIV/AIDS Rep, 6 (2009), pp. 77-82
  • J.M. Palefsky, E.A. Holly, C.J. Hogeboom, M.L. Ralston, M.M. DaCosta, R. Botts Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men J Acquir Immune Defic Syndr Hum Retrovirol, 17 (1998), pp. 314-319
  • N.F. Crum Cianflone, K.H. Hullsiek, V.C. Marconi, A. Ganesan, A. Wintrob, R.V. Barthel Anal cancers among HIV-infected persons: HAART is not slowing rising incidence AIDS, 24 (2010), pp. 535-543
  • A.R. Giuliano, J.M. Palefsky, S. Goldstone, E.D. Moreira Jr., M.E. Penny, C. Aranda Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males N Engl J Med, 364 (2011), pp. 401-411
  • M. Shcherba, J. Shuter, M. Haigentz Jr. Current questions in HIV-associated lung cancer Curr Opin Oncol, 25 (2013), pp. 511-517
  • E.A. Engels Non AIDS defining malignancies in HIV infected persons: etiologic puzzles, epideiologic perils, prevention oportunities AIDS, 23 (2009), pp. 875-885
  • N. Merchante, E. Merino, J. López Aldeguer, F. Jover, M. Delgado Fernández, M.J. Galindo Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain Clin Infect Dis, 56 (2013), pp. 143-150
  • R.L. DeBiasi, K.L. Tyler Molecular methods for diagnosis of viral encephalitis Clin Microbiol Rev, 17 (2004), pp. 903-925
  • K.R. Steingart, H. Sohn, I. Schiller, L.A. Kloda, C.C. Boehme, M. Pai, N. Dendukuri Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults Cochrane Database Syst Rev, 1 (2013), p. CD009593
  • M.J. Espy, J.R. Uhl, M.L. Sloan, S.P. Buckwalter, M.F. Jones, E.A. Vetter Real Time PCR in clinical microbiology: Applications for routine laboratory testing Clin Microbiol Rev, 19 (2006), pp. 165-256
  • K. Buchacz, R.K. Baker, F.J. Palella Jr., J.S. Chmiel, K.A. Lichtenstein, R.M. Novak AIDS defining opportunistic illnesses in US patients, 1994-2007: a cohort study AIDS, 24 (2010), pp. 1549-1559
  • R. Stratton, G. Slapak, T. Mahungu, S. Kinloch de Loes Autoinmunity and HIV Curr Opin Infect Dis, 22 (2009), pp. 49-56
  • B.Y. Nguyen, J.D. Reveille Rheumatic manifestations associated with HIV in the highly active antiretroviral therapy era Curr Opin Infect Dis, 21 (2009), pp. 404-410
  • N. Patel, N. Patel, T. Khan, N. Patel, L.R. Espinoza HIV infection and clinical spectrum of associated vasculitides Curr Rheumatol Rep, 13 (2011), pp. 506-512
  • N. Patel, N. Patel, L.R. Espinoza HIV infection and rheumatic diseases: the changing spectrum of clinical enigma Rheum Dis Clin N Am, 35 (2009), pp. 139-161
  • E.J. Cepeda, F.M. Wiliams, M.L. Ishimori, M.H. Wisman, J.D. Reveille The use of antitumour necrosis factor therapy in HIV positive individuals with rheumatic disease Ann Rheum Dis, 67 (2008), pp. 710-712
Data source: Dialnet